Healthy Clinical Trial
Official title:
KickStart30: A 30-Day Intervention for Patients With Rheumatoid Arthritis (RA)
This study explores the efficacy and feasibility of a self-management wellness intervention that is integrated, prescriptive, and trackable in a population of patients with Rheumatoid Arthritis (RA) taking a biologic. This 30-day wellness intervention (called "KickStart30") combines five wellness elements: exercise, mindfulness, sleep, social connectedness, and nutrition. Additionally, the program requires that participants implement 5 wellness interventions daily for the 30-day study, document daily online adherence, complete daily HERO (happiness, enthusiasm, resilience, and optimism) exercises to improve mental wellness, and complete online program forms before and after the 30-day intervention. Participants are assessed pre- and post-intervention to determine whether the intervention promotes wellness behavior changes.
It is expected that this 30-day integrated, prescriptive, and trackable wellness intervention
(combining five wellness elements including exercise, mindfulness, sleep, social
connectedness, and nutrition) will be found to be an efficacious program for those with
Rheumatoid Arthritis taking a biologic or a JAK inhibitor.
Traditionally mental health and other specialties like rheumatology have focused primarily on
the diagnosis and treatment of illness rather than incorporating wellness as an essential
element of treatment. Those in the helping professions are trained to diagnose health
problems with treatment typically focusing on symptom reduction. More recently, mental health
and other healthcare specialties like rheumatology have initiated a conversation and
subsequent research focusing on the importance of integrating elements of wellness into
treatment. Rather than focusing solely on symptom reduction, some providers have begun
incorporating elements of wellness promotion into treatment with favorable results.
To the best of our knowledge, even though there is abundant research supporting each of the
KickStart30 elements (exercise, mindfulness, sleep, social connectedness, and nutrition)
individually, there is no research exploring the effectiveness of an integrated,
prescriptive, and trackable wellness intervention combining these five elements specific to a
cohort of patients with RA. Therefore, this work will be unique in that it will collect both
objective and subjective data to assess the feasibility and effectiveness of this type of
wellness intervention. It will lend support to the growing body of research on the efficacy
of wellness interventions for a variety of different health conditions, as well as a
community-based population. Finally, it is hoped that positive results will yield increased
access to and utilization of this type of intervention, thereby improving public health.
The recruitment period will be open for 12 months to obtain a maximum of 50 participants. The
study population will be individuals, ages 18 and older, interested in improving their
overall wellness and that self-identify as having Rheumatoid Arthritis and taking a biologic
or a JAK inhibitor. Each participant will be engaged in the program for 30 days. To determine
a participant's eligibility, study personnel will conduct a preliminary screening/orientation
telephone interview. If the participant is determined to be eligible for the study based on
the preliminary screening/orientation phone interview, study personnel will collect the
participant's email address, physical mailing address, and assign the participant a unique
identification code based on the order in which the participant was screened. The consent
form outlines the purpose and design of the study, data to be collected, confidentiality
standards, alternatives to participation, and contact information for research personnel.
Participants will have the option to download a PDF of their signed consent form for their
records at the time of signing/completion.
Study personnel will mail each participant a KickStart30 Workbook within one day of emailing
participants their unique identification codes. Participants will be instructed to document
adherence of their daily wellness practices and their daily HERO exercises online via
Qualtrics, an online survey software. Participants can document their daily adherence using
their computer and/or their smartphone as Qualtrics offers a mobile version of the
Participant Tracking Form. A copy of the Participant Tracking Form will also be available in
the KickStart30 Workbook so participants that prefer keeping a daily paper log can do so, and
they can then transfer their program adherence information to the online Participant Tracking
Form at their convenience throughout the program. The workbook will contain the participant's
personal identification code; no personal identification will appear in the workbook in order
to protect participant confidentiality. Participants will also receive daily motivational
emails from MailChimp, which will provide general information about one of the five wellness
elements and/or one of the HERO wellness traits, as well as encouragement to track their
participation on a daily basis, and encouragement to contact study personnel via email with
any questions and/or concerns.
Data capture will occur at two points: once prior to beginning the study and again at the end
of the 30-day study. Data will be collected online through program forms; all data will be
hosted on Qualtrics, an online survey software. Program Forms assess items including
depression, anxiety, wellbeing, mindfulness, sleep quality, social connectedness, emotional
eating, pain, disability, physical function, happiness, enthusiasm, resilience, and optimism
in patients with RA.
Descriptive statistics will be used to discuss pre- and post-intervention scores. Differences
between pretest and 30-day measures will be assessed with repeated measures ANOVA, with a p
value of less than 0.05 indicating statistical significance.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |